Trumpf strengthens Eastern European position
Trumpf has strengthened its position within Hungary through the acquisition of the Lasersystems sales agency as the company continues to expand its presence in Central and Eastern Europe. The merger was announced just weeks after a number of managerial changes within the Trumpf group.
‘The entire Central and Eastern European region with Hungary, Romania, and Bulgaria represents a strategically important and exciting market for us,’ explained Dr Gerhard Rübling, member of the Trumpf Managing Board. ‘To be flexible and to offer our customers the best possible service, we're strengthening our local presence and extending it further – because, for us, proximity to our customers is one of the most important cornerstones of a successful collaboration.’
Business operations of Lasersystems will continue at the Budapest site as the laser technology division of Trumpf Hungary. Twenty sales and service employees will offer customers solutions for diverse industrial applications.
At the end of the 2013/14 financial year (30 June 2014) Trumpf appointed Lars Grünert as CFO, taking over the duties of Harald Völker, who stepped down. Lars Grünert has been working for Trumpf since 2002 and executive vice president of Trumpf since 2010. Until now, Grünert was CFO of the Laser Technology and Electronics Division for the group. He also held the interim role of president and CEO at Trumpf’s North American company, Trumpf Inc, for the past year and has been succeeded by Peter Hoecklin.
Hoecklin is now responsible for all Trumpf Inc.’s subsidiaries and business operations in North America, including manufacturing, engineering, research and development, customer service, technical training, product sales, and applications. He has since served the company in Germany and Asia, most recently as president and managing director of Trumpf China.
Völker, who steps down after two decades of work for Trumpf, held positions of both chairman of the Medical Technology Division and CFO. ‘Harald Völker played a decisive role in shaping the worldwide success of our company in the past two decades and I am very grateful to him for that,’ stated Nicola Leibinger-Kammüller, chairwoman of the Trumpf Management Board. ‘He made our Medical Technology Division a highly regarded player in the market. Moreover, it is largely thanks to him that we as a company were able to cope with the great crisis so well after 2008.’